OAKTREE CAPITAL MANAGEMENT LP - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 44 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
OAKTREE CAPITAL MANAGEMENT LP ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2020$13,444,000
+261.6%
13,428,000
+283.7%
0.29%
+178.1%
Q1 2020$3,718,000
-74.6%
3,500,000
-73.3%
0.10%
-21.1%
Q4 2018$14,628,000
-11.5%
13,120,000
-4.4%
0.13%
-40.1%
Q3 2018$16,527,000
+177.9%
13,720,000
+174.4%
0.22%
+167.5%
Q2 2018$5,947,000
-80.7%
5,000,000
-80.7%
0.08%
-82.8%
Q4 2017$30,822,000
+153.8%
25,915,000
+159.2%
0.48%
+166.9%
Q3 2017$12,142,000
+103.5%
10,000,000
+100.0%
0.18%
+84.7%
Q2 2017$5,968,000
-83.1%
5,000,000
-78.4%
0.10%
-73.7%
Q1 2015$35,265,000
-59.8%
23,188,000
-67.7%
0.37%
-60.3%
Q4 2014$87,691,000
+18.8%
71,763,000
+7.4%
0.94%
-23.4%
Q3 2014$73,802,000
+4.8%
66,800,0000.0%1.22%
-0.3%
Q2 2014$70,446,000
+0.1%
66,800,000
+6.0%
1.23%
-7.6%
Q1 2014$70,357,000
+73.6%
63,045,000
+68.1%
1.33%
+78.3%
Q4 2013$40,523,00037,500,0000.74%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q3 2018
NameSharesValueWeighting ↓
Birch Grove Capital LP 5,000,000$5,003,0002.71%
Weiss Asset Management LP 65,841,000$64,360,0002.62%
Davide Leone & Partners Investment Co Ltd. 10,500,000$10,513,0001.19%
TENOR CAPITAL MANAGEMENT Co., L.P. 29,597,000$29,800,0001.14%
GLAZER CAPITAL, LLC 7,483,000$7,474,0000.36%
BLUEFIN CAPITAL MANAGEMENT, LLC 52,500$5,243,0000.33%
OAKTREE CAPITAL MANAGEMENT LP 13,428,000$13,444,0000.29%
CSS LLC/IL 5,500,000$5,498,0000.26%
Kohlberg Kravis Roberts & Co. L.P. 40,182,000$40,159,0000.23%
EDMOND DE ROTHSCHILD HOLDING S.A. 2,606,000$2,606,0000.10%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders